2 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
Follow Emergencies: new trials by email Literature Review of Emergencies trials Research Report on Emergencies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Virginia Opioid Treatment-Emergency Department SUBLOCADE - Opioid Use Disorder | Phase 3 | Withdrawn | Virginia Commonwealth University | 2021-01-01 | 2021-02-12 | |
| Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE) Tolvaptan, placebo - Acute Heart Failure | Phase 3 | Withdrawn | Maisel, Alan, M.D. | 2024-11-20 |
Diabetes Insipidus (1) · Opioid-Related Disorders (1)
Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Chemically-Induced Disorders (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Pituitary Diseases (1) · Substance-Related Disorders (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Maisel, Alan, M.D. (1) · Virginia Commonwealth University (1)
Alan S Maisel, MD (1) · Frederick G Moeller, MD (1)